NCT01495377View on ClinicalTrials.gov

Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Opioid Induced Swallowing Disorders
Interventions
DRUG

Remifentanil

Powder for injection/ infusion fluid solution, 1 mg Infusion TCI 3 ng/ml 60 min ( 0,15 ug/kg/min)

DRUG

Placebo

Infusion fluid, solution 9 mg/ml ( hydrogenic solution )

DRUG

Technetium

37-40 MBq( effective dose 0,7 mSv) 99Tc albumin colloid in a volume of 6 ml, infusion velocity 0,1 ml/min via a transnasal catheter

DEVICE

Dynamometer (Jamar)

portable hydraulic hand dynamometer to assess grip strength.

Trial Locations (2)

70185

Örebro University Hospital, Örebro

701 85

University Hospital in Örebro, Örebro

All Listed Sponsors
lead

Region Örebro County

OTHER

NCT01495377 - Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration | Biotech Hunter | Biotech Hunter